CALCICO THERAPEUTICS LIMITED

Company number 07948431

Date	Type	Description	View / Download
13 Oct 2020	GAZ2(A)	Final Gazette dissolved via voluntary strike-off	(1 page)
14 Jul 2020	GAZ1(A)	First Gazette notice for voluntary strike-off	(1 page)
01 Jul 2020	DS01	Application to strike the company off the register	(3 pages)
20 May 2020	SH20	Statement by Directors	(1 page)
20 May 2020	SH19	Statement of capital on 20 May 2020 GBP 6,043.554	(3 pages)
20 May 2020	CAP-SS	Solvency Statement dated 14/05/20	(1 page)
20 May 2020	RESOLUTIONS	Resolutions RES13 ‐ Reduce share prem a/c 14/05/2020	(2 pages)
17 Feb 2020	CS01	Confirmation statement made on 14 February 2020 with updates	(5 pages)
28 Nov 2019	SH06	Cancellation of shares. Statement of capital on 11 November 2019 GBP 6,043.554	(4 pages)
15 Nov 2019	SH03	Purchase of own shares.	(3 pages)
31 Aug 2019	TM01	Termination of appointment of Roberto Celeste Ercole Solari as a director on 30 August 2019	(1 page)
15 Aug 2019	AA	Accounts for a small company made up to 30 December 2018	(12 pages)
14 Feb 2019	CS01	Confirmation statement made on 14 February 2019 with updates	(5 pages)
12 Dec 2018	AA	Accounts for a small company made up to 30 December 2017	(16 pages)
28 Nov 2018	SH01	Statement of capital following an allotment of shares on 28 November 2018 GBP 6,366.521	(4 pages)
20 Nov 2018	SH01	Statement of capital following an allotment of shares on 16 November 2018 GBP 6,360.321	(4 pages)
05 Nov 2018	TM01	Termination of appointment of Andrew John Wood as a director on 31 October 2018	(1 page)
05 Nov 2018	TM01	Termination of appointment of Anant Parekh as a director on 31 October 2018	(1 page)
23 Oct 2018	AD02	Register inspection address has been changed from C/O Kelly Chessum 40 Rookery Road Wyboston Bedford Beds MK44 3AX England to Advent Life Sciences Ltd 158-160 North Gower Street London NW1 2nd	(1 page)
22 Oct 2018	AD01	Registered office address changed from Oxford Science Park, Magdalen Centre Robert Robinson Avenue Oxford OX4 4GA to Advent Life Sciences Ltd 158-160 North Gower Street London NW1 2nd on 22 October 2018	(1 page)
10 Sep 2018	AA01	Previous accounting period shortened from 31 December 2017 to 30 December 2017	(1 page)
18 Apr 2018	AP02	Appointment of Ip2Ipo Services Ltd as a director on 18 April 2018	(2 pages)
18 Apr 2018	TM01	Termination of appointment of Daniel Bach Gonzalez as a director on 18 April 2018	(1 page)
21 Feb 2018	CS01	Confirmation statement made on 14 February 2018 with updates	(7 pages)
21 Feb 2018	PSC05	Change of details for Imperial Innovations Businesses Llp as a person with significant control on 27 November 2017	(2 pages)